News
2023-01-31
Cellectricon strengthens IP portfolio – Receives “Intention to Grant” from the European Patent Office
Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention...
Events
November 12-16, 2022
Neuroscience 2022
The Neuroscience 2022 meeeting takes place in San Diego on November 12-16. During the conference, we will present several posters...
Events
October 11, 2022
Nordic Health Meet 2022
Cellectricon are proud presenters at the Nordic Health Meet 2022 at the Embassy of Sweden in Tokyo on October 11....

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
September 29, 2022
Webcast - Validation of an in vitro α-synuclein aggregation assay for target discovery in neurodegenerative disease research
Event info: In this webcast, Paul Karila, Head of Drug Discovery, and Johan Pihl, Chief Operating Officer, discuss the development...
Events
September 19-23, 2022
World Congress on Pain
The IASP 2022 World Congress on Pain takes place in Toronto, Canada and online on September 19-23, 2022. At the...
Events
May 16-17, 2022
Neuro4D
The Neuro4D conference takes place in Mainz, Germany on May 16-17, 2022. With a focus on neurodegenerative disease drug discovery,...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
May 10-12, 2022
Advances in Cell-based Screening
ELRIG’s meeting on Advances in Cell-based Screening 2022 takes place at AstraZeneca in Gothenburg, Sweden on May 10-12, 2022. The...
Events
May 8-10, 2022
Target to Patient
The Target to Patient meeting takes place at the Wellcome Genome Campus in Hinxton, UK on May 8-10, 2022. The...
Events
March 15-20, 2022
AD/PD 2022
The AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders took place in Barcelona, Spain and...